Bandaru S. Reddy

Prevention of colon cancer by pre- and probiotics: evidence from laboratory studies

Bandaru S. Reddy, B. Reddy, 1998, British Journal of Nutrition.

Role of Synthetic and Naturally Occurring Cyclooxygenase Inhibitors in Colon Cancer Prevention

C. Rao, Bandaru S. Reddy, B. Reddy, 2003 .

Preclinical efficacy evaluation of potential chemopreventive agents in animal carcinogenesis models: Methods and results from the NCI chemoprevention drug development program

V. Steele, C. Boone, C. Sigman, 1994, Journal of cellular biochemistry. Supplement.

Omega‐3 fatty acids in colorectal cancer prevention

Bandaru S. Reddy, B. Reddy, 2004, International journal of cancer.

Regression of Mouse Prostatic Intraepithelial Neoplasia by Nonsteroidal Anti-inflammatory Drugs in the Transgenic Adenocarcinoma Mouse Prostate Model

B. Pittman, N. Narayanan, B. Narayanan, 2004, Clinical Cancer Research.

Chemoprevention of cancer by organoselenium compounds

E. Fiala, C. Rao, O. Sohn, 1995, Journal of cellular biochemistry. Supplement.

16S Ribosomal DNA Terminal Restriction Fragment Pattern Analysis of Bacterial Communities in Feces of Rats Fed Lactobacillus acidophilus NCFM

C. Kaplan, C. Kitts, M. Sanders, 2001, Applied and Environmental Microbiology.

ASSESSING THE P ATTERN OF DRUG USE A MONG PREGN ANT WOMEN AND EVALUATING THE IMPAC T OF COUNSELLING ON MEDICATION ADHERENCE AMONG THEM

Bandaru S. Reddy, N. Patil, 2011 .

Novel approaches for colon cancer prevention by cyclooxygenase-2 inhibitors.

C. Rao, Bandaru S. Reddy, B. Reddy, 2002, Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer.

Molecular Markers in Chemoprevention of Colon Cancer

B. Reddy, J. Singh, Bandaru S. Reddy, 1995, Annals of the New York Academy of Sciences.

Dietary factors in human colorectal cancer.

M. Lipkin, S. Lamprecht, H. Newmark, 1999, Annual review of nutrition.

Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.

V. Steele, K. Seibert, G. Kelloff, 2000, Cancer research.